The v-raf murine sarcoma viral oncogene homolog B1 (BRAF) gene is mutated in 40–60 % of melanomas, the most common being the V600E mutation, which leads to over-activation of the mitogen-activated protein kinase (MAPK) pathway [1, 2]. This evidence concerns the gene BRAF and melanoma.